Details of the Drug

General Information of Drug (ID: DMZQBCL)

Drug Name
LR3001
Indication
Disease Entry ICD 11 Status REF
Myeloid leukaemia 2B33.1 Phase 2 [1]
Therapeutic Class
Anticancer Agents
Drug Type
Antisense drug
Cross-matching ID
TTD ID
D01MZJ

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Myb messenger RNA (MYB mRNA) TT8V13P MYB_HUMAN Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Myeloid leukaemia
ICD Disease Classification 2B33.1
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Myb messenger RNA (MYB mRNA) DTT MYB 1.07E-11 0.34 0.74
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Pipeline report of Genta.
2 Genta obtains orphan drug designation for C-Myb Antisense (LR3001) in chronic myelocytic leukemia. Genta. 2005.